Although psoriasis most commonly presents with skin manifestations, patients can have significant joint involvement indicative of psoriatic arthritis. Targeted biologic therapies are available to treat psoriatic arthritis, so it is imperative that providers recognize joint manifestations in patients with psoriasis and collaborate with rheumatologists to implement guideline-directed therapy to effectively decrease the risk of future joint damage in these patients. In this activity, expert faculty discuss a patient with psoriasis who presents with new symptoms that raise concerns about psoriatic arthritis.
The educational design of this activity addresses the needs of dermatologists involved in the treatment of patients with psoriatic arthritis.
Anthony P. Fernandez, MD, PhD
Assistant Professor of Clinical Medicine, CCLCM
Director of Medical Dermatology
W.D. Steck Chair of Clinical Dermatology
M. Elaine Husni, MD, MPH
Assistant Professor of Medicine
Case Western Reserve University Lerner College of Medicine
Vice Chair, Department of Rheumatic and Immunologic Diseases
After completing this activity, the participant should be better able to:
- Comprehensively assess patients with psoriasis for potential clinical manifestations, multisystem effects, and patient-reported outcomes
- Describe strategies to effectively collaborate with rheumatology colleagues to optimize the care of patients with psoriatic arthritis
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Integritas Communications. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity for 0.25 contact hour is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Instructions to Receive Credit
To receive credit for this activity, participants must complete the preactivity questionnaire, complete and receive a minimum score of 100% on the posttest, and complete the program evaluation.
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or email@example.com.
There is no fee for this educational activity.
Disclosures of Relevant Financial Relationships
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
Anthony P. Fernandez, MD, PhD:
Consultant: AbbVie Inc., Bristol Myers Squibb Company, UCB, Inc.
Contracted research: AbbVie Inc., Alexion Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Novartis Pharmaceuticals Corporation, Pfizer Inc.
Honoraria: AbbVie Inc., Bristol Myers Squibb Company, Kyowa Kirin, inc., UCB, Inc.
Speakers Bureau: AbbVie Inc., Kyowa Kirin, Inc., Mallinckrodt Pharmaceuticals, Novartis Pharmaceuticals Corporation
M. Elaine Husni, MD, MPH:
Consulting Fees: AbbVie Inc., Bristol Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Novartis Pharmaceuticals Corporation, UCB, Inc.
The Global and Integritas Communications planners and managers have nothing to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Global Education Group (Global) and Integritas Communications do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.